HIV type 1 lipopeptide vaccine

includes 6 lipopeptides (N1-3, G1-2, E); well tolerated and able to induce a specific CD4(+) and CD8(+) T cell responses; in clinical trials phase II 7/2006

Also Known As:

Networked: 0 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results